NSDL IPO GMP hints at 17% listing gains but pre-IPO investors still nursing losses

Wait 5 sec.

NSDL’s IPO, priced 22% below its last unlisted valuation, stirred mixed reactions—pre-IPO investors face notional losses, while public investors see upside via 17% grey market premium. The full OFS structure, realistic P/E ratio, and broader trend of valuation correction reflect a shift toward sustainable public market pricing.